Pharmacological inhibition of the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; generally known as FRAP-associated protein (FRP1)) has emerged as being a promising approach for cancer procedure that exploits synthetic lethal interactions with proteins linked to DNA hurt restore, overcomes resistance to other therapies and improves antitumour immunity. A https://raymonds998eqa1.fare-blog.com/profile